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The mTOR kinase forms two multicomponent protein complexes (mTORC1 and mTORC2), where protein 
Rictor is a unique component of mTORC2. These two complexes differ both structurally and functionally and 
transmit signals to distinct downstream substrates. In contrast to mTORC1, comparatively little is known 
about functioning and regulation of mTORC2 and its components. Aim. The analysis of the particularity of 
Rictor subcellular localization in MCF7 cells. Methods. Immunofluorescence assay using confocal micros-
copy was applied. Results. Analysis of Rictor localization with anti N-terminal mAb revealed a different pat-
tern of immunostaining in cells that was depended on cell cycle phase. For the first time it was shown that 
Rictor is at the exposed edge of condensed chromatin pool in MCF7 cells. Furthermore Z-stacking of cells 
revealed that character of association depends on mitosis phases. Conclusions. Our novel findings add to our 
understanding of functioning of both Rictor and mTORC2 in cell cycle progression.
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Introduction
The mammalian target of rapamycin (mTOR) is ki-
nase well conserved from yeast to mammals. It plays 
a central role in regulation of cellular homeostasis, 
cell growth and survival pathways by acting as a sen-
sor for upstream inputs from multiple nutrient signals 
[1, 2]. In mammals, there are two multicomponent 
mTOR protein complexes [1, 2]: mTORC1 and 
mTORC2 which differs both structurally and func-
tionally and signal to distinct downstream substrates. 
The mTORC1 is composed of catalytic subunit 
mTOR, the regulatory-associated protein of mTOR 
(Raptor), mLST8 (also known as GβL), PRAS40, 
Deptor and the Tti1/Tel2 complex [3]. The activity 
of the mTORC1 complex is highly regulated in cells 
exposed to growth factors and nutrients and is sensi-
tive to macrolide rapamycin [4]. The best-character-
ized mTORC1 kinase substrates include S6K and 
4E-BP1 [4]. 
The mTORC2 complex includes catalytic subunit 
mTOR, rapamycin-insensitive companion of mTOR 
(Rictor), mSIN1, Protor-1/2, mLST8, Deptor and the 
Tti/Tel2 complex [5–10]. mTORC2 is relatively ra-
pamycin-insensitive and thought to modulate growth 
factor signaling by phosphorylating the C-terminal 
hydrophobic motif of some AGC kinases such as Akt 
[11], SGK [12], and PKC alpha [13, 14]. In contrast to 
mTORC1, comparatively little is known about 
mTORC2 biology. It has been demonstrated that 
mTORC2 plays key roles in cell survival, metabo-
lism, proliferation and cytoskeleton organization but 
the detailed mechanism remains to be addressed. 
Although Rictor was originally identified as a novel 
binding partner of mTOR to regulate cell morphology 
and migration by playing a role as the indispensable 
component of mTORC2, it is likely that Rictor carry-
ing mTORC2-independent functions also. In support 
of this notion Rictor has been found to associate with 
other proteins independently of mTOR, such as cul-
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lin-1 (to promote SGK1 ubiquitination and destruc-
tion) [15], Myo1c (Rictor-Myo1c complex participates 
in dynamic cortical actin events in 3T3-L1 adipocytes) 
[16], integrin-linked kinase (ILK) (to regulate Akt 
phosphorylation and cancer cell survival) [17], and 
PKCζ (to regulate cancer cell metastasis) [18].
To provide novel insights regarding functioning 
of mTORC2 complex as well as unique functional 
roles of the Rictor protein, which are independent 
from its better characterized role as an interacting 
protein with mTOR, subcellular distribution of 
Rictor during different stages of mitosis was ana-
lyzed. This analysis revealed for the first time that 
Rictor associates with chromosomes and this asso-
ciation depends on the stage of mitosis.
Materials and Methods
Cell culture and antibodies
MCF7 cell line was cultured at 37 °C in humidified incu-
bator with 5 % CO2. For routine cell culture, the human 
MCF7 were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) (HyClone, Sigma, USA) supple-
mented with 10 % fetal bovine serum (FBS) (HyClone, 
Sigma, USA) and penicillin 50 unit/ml (Sigma, USA) 
and streptomycin 50 mkg/ml (Sigma, USA).
The mouse monoclonal antibody against Rictor 
was developed previously in our laboratory [19].
Immunofluorescence analysis
MCF-7 cells cultured on cover glasses were fixed 
with methanol for 5 min at room temperature. 
Thereafter, the cells were treated with 0.2 % Triton 
X100 in PBS for 15 min. The samples were incubated 
for 20 min in 10 mM cupric sulphate in 50 mM am-
monium acetate, pH 5.0, to eliminate autofluores-
cence. Non-specific binding was blocked after incu-
bation with 10 % FCS for 40 min at 37 °C. Antibodies 
obtained from clone D4 (anti-Rictor) were used in the 
concentration of 1 μg/ml. The secondary FITC conju-
gated anti-mouse antibodies were applied in dilution 
1:100 (Jackson ImmunoResearch, West Grove, PA, 
USA). As negative control MCF7 cells were incubat-
ed with secondary FITC conjugated anti-mouse anti-
bodies alone. Nuclei were counterstained with PI 
(Sigma, USA). All microscopy studies were per-
formed using Zeiss LSM 510 META microscope 
(CarlZeiss Microscopy GmbH, Jena, Germany).
Results
Rictor distribution in interphase cells
Immunofluorescence assay using antibodies against 
Rictor protein previously generated in our laboratory 
[19] was performed on MCF-7 cell line. Mouse 
monoclonal antibody D4 mAb against N-terminal 
peptide of human Rictor is highly specific in Western 
blot and in immunofluorescence assay [19]. 
Here Rictor’s subcellular distribution in human 
breast adenocarcinoma cell line MCF7 was exam-
ined. A uniform speckled cytoplasmic distribution of 
the endogenous Rictor as well as immunostaining of 
Rictor in nuclei was detected. Rictor is located on 
the nuclear envelope, and the nuclear pattern includ-
ed punctate bodies, small dot-like speckles and 
speckles in all interphase cells (Fig. 1). Moreover, at 
the same sample changes in pattern of Rictor distri-
bution in metaphase cells was detected: besides cy-
toplasmic Rictor distribution and its intense accumu-
lation on condensed chromatin was observed. To 
shed a light on this phenomenon I focused on Rictor 
distribution at different stages of mitosis. 
Distribution of Rictor in MCF-7 cells during 
mitosis
To determine the dynamic distribution of Rictor in the 
cells during mitosis, chromosomal DNA was stained 
with PI to show the cell phase (red), and Rictor was 
detected with (D4 mAb) and FITC conjugated goat 
anti-mouse IgG (see “Materials and Methods”). The 
samples were examined by confocal laser microscopy 
(Fig. 2). At prophase the chromatin begins to condense, 
the amount of Rictor small dot-like speckles and speck-
les were significantly increase comparing to interphase 
cells. At metaphase all chromosomes compacted on the 
equatorial plate and shaped as cylinder-like entity. The 
green fluorescent signals of the Rictor on borders of the 
cylinder were much stronger than that at the center. 
424
O. M. Malanchuk
Fig. 1. Subcellular distribution of Rictor in 
MCF7 cells.
PI, chromosomal DNA stained with PI; 
FITC, Rictor stained by immunofluores-
cence with FITC conjugated antibody; 
Merge, merged image of the PI and FITC 
staining. Arrows indicate mitotic cells
Fig. 2. Dynamic distribution of Rictor in 
interphase and at different stages of mito-
sis in MCF7 cells.
Column PI, chromosomal DNA stained 
with PI; Column FITC, Rictor stained by 
immunofluorescence FITC conjugated an-
tibody; Column Merge, merged image of 
the PI and FITC staining
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Some of strong fluorescent immunostaining was local-
ization on the border of the cylinder of the condensed 
chromosome; namely, the Rictor protein location is 
overlapping with condensed chromosome (yellow). It 
indicates the association of Rictor with chromosomes. 
When sister chromosomes were getting apart after cen-
tromeric fission, the cells enter anaphase. There is 
stronger fluorescent signal of Rictor in the separating 
chromosomes in outer pool of condensed chromatin in 
compare to metaphase cells forming a “ring”-like struc-
ture. At telophase the separated chromosomes started to 
uncoil and became less condensed, immunofluores-
cence in outer pool of chromatin was considerably 
weaker and tended to one in interphase cells.
Determination of character of Rictor associa-
tion with chromatin
To determine the character of Rictor association with 
chromatin Z-stacking was performed and allow us to 
obtain a composite image of multiple images taken 
Fig. 3. Z-Stack of mitotic MCF7 cells.
A – Z-stack was performed using confocal 
microscopy. A picture of the cell was taken 
on several planes, ranging from upper to 
lower levels. Images demonstrate that Ric-
tor is exposed on the surface of condensed 
chromatin pool only (yellow). A. Upper 
image of cells. B – E. Every next image 
was taken in 1 μm deeper than previous 
one. Column PI, chromosomal DNA 
stained with PI; Column FITC, Rictor 
stained by immunofluorescence with FITC-
conjugated antibody; Column Merge, 
merged image of the PI and FITC staining
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at different focal distances [20]. 5 slices per Z-stack 
with 1 μm z-step of mitotic cells revealed that Rictor 
is localized at the exposed edge of condensed chro-
matin pool only (yellow) (see Fig. 3).
Discussion
There are controversial data about localization of 
mTORC1 and mTORC2 complexes and its compo-
nents in the cell [21]. mTORC1 localization is well 
characterized in mammalian cells. Newest data demon-
strate a wide distribution of mTORC1 in the plasma 
membrane, cytosol, lysosome and the nucleus although 
in some cases the evidence is questionable [21–23]. In 
contrast to mTORC1, the mTORC2 localization is 
more obscure. Recently Betz et al. revealed that 
mTORC2 localizes at mitochondria-associated ER 
membranes [24]. Another group shown that mTORC2 
detected in a minor fraction on lipid rafts at the plasma 
membrane [18]. Moreover, there is evidence that 
mTORC2 is localized in the nucleus [24–27], while a 
nuclear function for mTORC2 is so far unknown. 
Intriguing, recently Sarbassov’s group has discovered 
novel localization of mTOR on nuclear envelope where 
it associates with a critical regulator of nuclear import 
RanBP2 [28]. This association is dependent on the 
mTOR kinase activity and is not affected by inhibition 
of mTORC1 or deficiency of mTORC2 [28]. 
There are longstanding speculations about subcel-
lular localization of Rictor and mTORC2. Although 
Rictor and mTORC2 can to be localized to the cyto-
plasm and the nucleus it is still unclear how transloca-
tion from the cytoplasm into the nucleus is regulated 
and what is the functional relevance of this transition. 
In the present study, indirect immunofluorescent la-
beling and confocal laser microscopy was used to exam-
ine subcellular localization of Rictor protein and dynam-
ic of its distribution in human breast adenocarcinoma 
cell line MCF7 at mitosis. The results show that Rictor 
has primarily uniform speckled cytoplasmic distribution. 
Immunostaining of Rictor in the nucleus indicates its lo-
cation on the nuclear envelope, and the varying minor 
nuclear staining pattern in interphase cells. The detailed 
analysis of mitotic MCF7 cells revealed the different pat-
tern of Rictor distribution characterized by accumulation 
on condensed chromatin and gradual increasing of its as-
sociation through mitotic stages. Moreover the dynamic 
distribution of Rictor in the MCF7 cells is correlated 
with mitosis progress temporally and spatially: Rictor 
was at the exposed edge of condensed chromatin pool 
only; the weak Rictor association with condensed chro-
matin started in minor at prophase of MCF7 cells and 
reached maximum at anaphase.
Chromatin is the complex of DNA and proteins 
that are packed within the nucleus of mammalian 
cells. Up to date little is known about the interaction 
of Rictor with DNA or DNA-binding proteins, such 
as histones or non-histone proteins. Rictor posseses 
two domains in its N-terminus (ARM-like and ARM-
type fold), which are the super-helical structures and 
presents an extensive solvent-accessible surfaces that 
are well suited to binding large substrates such as 
proteins and nucleic acids [29]. So, hypothetically, 
there is sufficient prerequisite for direct Rictor inter-
action with chromosomal DNA. The biological func-
tion of such interaction remains to be elucidated. 
The other possibility is that Rictor binds to his-
tones and thus determines the target of phosphoryla-
tion by mTORC2 whereupon phosphorylated histone 
gets involved in cytokinesis. But it is unclear whether 
such late histone phosphorylation is possible.
However, strong Rictor spreading all over the chro-
mosomes at metaphase and anaphase may suggest 
that it is able to bind exposed the telomeric regions of 
chromosomes. This binding might be either direct or 
indirect, mediated by telomere binding proteins and 
play role in maintaining of chromosome stability. 
The detection of one component of TORC2 com-
plex does not necessarily reflects localization of an 
entire complex. However, it is known that a majority 
of the Rictor staining overlaps with mTOR and this 
observation makes Rictor a valuable marker in pursu-
ing the subcellular localization of mTORC2 [30]. In 
conclusion, our findings are in agreement with the 
notion that mTOR complexes are hyperactive during 
mitosis and suggest that all or at least part of their 
components (e.g., Raptor [31–34] and Rictor) may 
physically and functionally interact with the mitotic 
and cytokinetic apparatus during cell division. It re-
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mains to be demonstrated the functional significance 
of Rictor association with chromatin as well as to 
determined its interacting target (DNA or proteins), 
besides to be elucidated whether Rictor acts alone or 
in complex with mTOR, and finally the precise 
mechanism of regulation of Rictor association dur-
ing mitosis and cytokinesis. 
Altogether, these novel findings add to our under-
standing of the Rictor complex, independent of 
mTOR, which may play a role in the regulation of 
cell proliferation. It will be of great interest for the 
future to investigate the molecular mechanisms by 
which mTORC2 complex or Rictor alone are func-
tioning and are regulated in normal and malignant 
cells, which will advance our understanding of this 
signaling network and facilitate the identification of 
potential targets for treating human cell division-re-
lated diseases, including cancer and aging.
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Асоціація Rictor з хромосомами під час мітозу 
в клітинах лінії MCF7
Маланчук О. М.
Кіназа mTOR формує два мультикомпонентних комплекси 
(mTORC1 та mTORC2, унікальним компонентом останнього є 
Rictor), які відрізняються як структурно, так і функціонально, та 
мають різні мішені. На відміну від mTORC1, відносно мало відо-
мо про функціонування і регуляцію комплексу mTORC2 і його 
компонентів. Мета. Аналіз особливостей субклітинної локаліза-
ції Rictor в клітинах MCF7. Методи. Імуно флуо рисцентний ана-
ліз із використанням конфокальної мікроскопії. Результати. 
Аналіз локалізації Rictor за допомогою моноклональних антитіл 
до N-термінального фрагменту Rictor продемонстрував диферен-
ційний патерн імунофарбування клітин в залежності від стадії 
клітинного циклу. Вперше виявлено значну поверхневу асоціацію 
Rictor з конденсованим хроматином в клітинах MCF7. Більш того, 
Z-стекінг клітин дав можливість зрозуміти характер асоціації, яка, 
як виявилось, залежить від фази мітозу. Висновки. Дані, отримані 
нами вперше, вносять вклад в розуміння функціонуваня як 
білкаRictor, так і комплекса mTORC2 в прогресії клітинного ци-
клу.
К л юч ов і  с л ов а: Rictor, mTORC2, імунофлюорисценція, 
субклітинна локалізація, мітоз.
Ассоциация Rictor с хромосомами во время митоза 
в клетках линии MCF7
Маланчук О. Н.
Киназа mTOR формирует два мультикомпонентных комплекса 
(mTORC1 и mTORC2, уникальным компонентом последнего 
является Rictor), которые отличаются как структурно, так и 
функционально и имеют разные мишени. В отличии от 
mTORC1, относительно мало известно о функционировании и 
регуляции комплекса mTORC2 и его компонентов. Цель. 
Анализ особенностей субклеточной локализации Rictor в клет-
ках MCF7. Методы. Иммунофлюорисцентный анализ с ис-
пользованием конфокальной микроскопии. Результаты. 
Анализ локализации Rictor с помощью моноклональных анти-
тел к N-терминальному фрагменту Rictor выявил дифференци-
альный паттерн иммуноокрашивания клеток в зависимости от 
стадии клеточного цикла. Впервые удалось показать значитель-
ную поверхностную ассоциацию Rictor с конденсированным 
хроматином в клетках MCF7. Более того, Z-стекинг клеток по-
зволил понять характер ассоциации, которая, как оказалось, за-
висит от фазы митоза. Выводы. Данные, полученные нами 
впервые, вносят вклад в понимание функционирования как 
белка Rictor, так и комплекса mTORC2 в прогрессии клеточно-
го цикла.
К л юч е в ы е  с л ов а: Rictor, mTORC2, иммунофлюорисцен-
ция, субклеточная локализация, митоз.
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